LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States. Sales in Germany also contribute a significant proportion of total revenue.
| Website: | www.lemaitre.com |
| Main Phone: | +1 781 221-2266 |
| Address: | 63 Second Avenue |
| State: | MA |
| City / Town: | Burlington |
| Country: | USA |
| Postal Code: | 01803 |
| Exchange: | NSD |
| CEO: | George W. Lemaitre |
| Employees: | 479 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
LeMaitre Vascular, Inc. (LMAT) is a medical devices company focused on vascular surgery. The company is a strong niche market brand that has an excellent bottom line.
The iconic Yahoo! (YHOO) sign went up in 1999 off the north side of highway 101 on the way into San Francisco, and had remained in the exact same spot since those exuberant days of the dot com
At www.ValuEngine.com we show that the Medical sector 12.6% overvalued with the medical Products industry 10.4% undervalued. All 12 stocks in today’s table have complete ValuEngine data and have
At www.ValuEngine.com we show that the Medical sector is 9.8% overvalued. The Medical Products industry is 4.2% overvalued. The Medical Services industry is 9.1% overvalued. The Medical
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States. Sales in Germany also contribute a significant proportion of total revenue.
| Website: | www.lemaitre.com |
| Main Phone: | +1 781 221-2266 |
| Address: | 63 Second Avenue |
| State: | MA |
| City / Town: | Burlington |
| Country: | USA |
| Postal Code: | 01803 |
| Exchange: | NSD |
| CEO: | George W. Lemaitre |
| Employees: | 479 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
LeMaitre Vascular, Inc. (LMAT) is a medical devices company focused on vascular surgery. The company is a strong niche market brand that has an excellent bottom line.
The iconic Yahoo! (YHOO) sign went up in 1999 off the north side of highway 101 on the way into San Francisco, and had remained in the exact same spot since those exuberant days of the dot com
At www.ValuEngine.com we show that the Medical sector 12.6% overvalued with the medical Products industry 10.4% undervalued. All 12 stocks in today’s table have complete ValuEngine data and have
At www.ValuEngine.com we show that the Medical sector is 9.8% overvalued. The Medical Products industry is 4.2% overvalued. The Medical Services industry is 9.1% overvalued. The Medical
| Last Price 27.35 | Change $ 1.07 | Change % 4.05 | Tick N/A |
| Bid 22.91 | Bid Size 100.00 | Ask 28.80 | Ask Size 100.00 |
| Open 26.60 | High 27.46 | Low 25.63 | Prev Close 26.29 |
| Last Trade | Volume 133,938 | 52 Wk Hi 38.64 | 52 Wk Low 18.77 |
| Market Cap 551.9 mi | Ex-Div Date | Div Rate 0.38 | Yield 1.3890 |
| Shares 20,178,506.00 | EPS (TTM) 0.86 | PE Ratio 30.60 | Exchange NSD |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 16 | 84 |
| Number of Buys | 3 | 34 |
| Number of Sells | 13 | 50 |
| Net Activity | -116485 | -322030 |
| Last 10 Buys | Shares |
|---|---|
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| John J. O'Connor | 1,000 |
| John J. O'Connor | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| Trent G. Kamke | 1,000 |
| Trent G. Kamke | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| George W. Lemaitre | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 40 | 40 | 40 | 40 |
| Low Target Price Estimate | 29 | 29 | 29 | 29 |
| Mean Target Price Estimate | 34.25 | 34.25 | 34.25 | 35 |
| Standard Deviation | 4.5 | 4.5 | 4.5 | 4.24 |
| Date of Most Recent Estimate | 05/15/18 | 05/15/18 | 04/26/18 | 06/08/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| SD | Specialized Disclosure Report | 3 | 2018-05-31 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-18 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.33 | 2.6 | 2.6 | 2.6 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait